SCHEMBL20127352

SCHEMBL20127352

c1ccc(-c2cc3oc4cc(-c5c6ccccc6c(-c6ccc7ccccc7c6)c6ccccc56)ccc4c3c3ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.39
CYP1A1 P04798 2/20 0.37
CYP1B1 Q16678 1/20 0.37
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
MAOB P27338 3/20 0.36
CYP1A2 P05177 2/20 0.36
AKR1B1 P15121 2/20 0.36
FYN P06241 1/20 0.36
MAPK3 P27361 1/20 0.36
AHR P35869 1/20 0.36
PAX8 Q06710 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
CA12 O43570 1/20 0.36
ALDH2 P05091 1/20 0.36
MAOA P21397 1/20 0.36
HSD17B3 P37058 1/20 0.36
SORD Q00796 1/20 0.36
CA9 Q16790 1/20 0.36
KDM4E B2RXH2 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127353 0.99 GPR84 (0.38) GPR84CYP1A1CYP1B1HSD17B1HSD17B2
SCHEMBL20127360 0.94 GSTP1 (0.40) GPR84CYP1A1CYP1B1CYP1A2ABCG2
SCHEMBL13507287 0.92 CYP1A1 (0.40) GPR84CYP1A1CYP1B1HSD17B1HSD17B2
SCHEMBL20906757 0.92 AKR1B1 (0.41) GPR84CYP1A1CYP1B1MAOBCYP1A2
SCHEMBL13507104 0.90 CYP1A1 (0.41) GPR84CYP1A1CYP1B1CYP1A2FYN
SCHEMBL20127354 0.90 MAPK9 (0.42) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL13506942 0.89 PGR (0.42) GPR84CYP1A1CYP1B1HSD17B1HSD17B2
SCHEMBL24586873 0.89 ALDH1A1 (0.41) GPR84CYP1A1CYP1B1HSD17B1HSD17B2
SCHEMBL20127356 0.89 WEE1 (0.41) GPR84CYP1A1CYP1B1CYP1A2FYN
SCHEMBL17931938 0.89 TDP1 (0.38) GPR84CYP1A1CYP1B1CYP1A2ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 GPR84 2389/4885CYP1A1 399/4885CYP1B1 341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.